Halda Therapeutics Opco, Inc.
Clinical trials sponsored by Halda Therapeutics Opco, Inc., explained in plain language.
-
New hope for advanced breast cancer: experimental drug HLD-0117 enters human testing
Disease control Recruiting nowThis early-phase study tests a new drug called HLD-0117 in about 33 women with a type of advanced breast cancer (ER-positive) that has spread or is locally advanced and has not responded to prior treatments. The main goals are to check the drug's safety and find the right dose. R…
Phase: PHASE1 • Sponsor: Halda Therapeutics OpCo, Inc. • Aim: Disease control
Last updated May 25, 2026 12:46 UTC
-
New hope for Hard-to-Treat prostate cancer: experimental drug HLD-0915 enters human trials
Disease control Recruiting nowThis early-stage study tests an experimental drug called HLD-0915 in men with metastatic castration-resistant prostate cancer (mCRPC) whose cancer has worsened despite standard treatments. The study has two parts: first, finding a safe dose, then testing how well that dose works.…
Phase: PHASE1, PHASE2 • Sponsor: Halda Therapeutics OpCo, Inc. • Aim: Disease control
Last updated May 20, 2026 11:58 UTC